MENU
KLTO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Klotho Neurosciences (KLTO) Ownership - Who owns Klotho Neurosciences?
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
56.57M
P/E Ratio
N/A
Total Cash
565.87K
Projected Growth
N/A
Total Debt
1.77M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KLTO
Capitalization
56.6M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
566K
Total Cash/Share
0.02
Total Debt
1.77M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
639K
P/B Ratio
88.50
Cash Flow
N/A
Earnings
-0.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.85K
Current Ratio
0.29
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-6.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-258.17
Shares Held By Institutions
262K
Shares Outstanding - Current
36.5M
Total Liabilities
2.35M
Total Volume MTD
N/A
Value
-1
Gain YTD
219.588
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information